[ad_1]
January 17, 2021 8:05 PM
236
On December 27, 2020, at an infectious disease hospital in Bucharest, the Romanian capital, medical staff showed the new crown vaccine to the media.
Previously, there have been several reports of adverse reactions to Pfizer vaccines, and the report of deaths in Norway brought people’s attention back to the vaccine.
13 deaths may be related to adverse reactions
The Norwegian Medicines Agency said in the announcement that 13 of the deaths have been evaluated. The cause of death may be related to adverse reactions such as fever and nausea caused by the vaccine. These adverse reactions can cause the death of frail elderly people.
The announcement stated that the messenger ribonucleic acid (mRNA) vaccine produced jointly by Pfizer and the German Biotechnology Company was not included in clinical trials for people with unstable physical conditions or acute illness, and few people over the age of 85 participated in the trial. . And Norway vaccinated some older people with serious underlying diseases.
The ad stated that adverse reactions such as fever and nausea within a few days after vaccination can cause aggravation or death of people with serious underlying illnesses. The Norwegian Institute of Public Health has updated its vaccination guidelines and presented more specific guidelines for vaccinating frail elderly.
WHO: Closely monitor the progress of the investigation
A spokesman for the World Health Organization said on the 15th that the World Health Organization learned that 23 people in Norway have died after being vaccinated by Pfizer and will closely monitor the progress of the health department’s investigation. Norwegian.
A WHO spokesperson told the Sputnik reporter in Geneva, Switzerland on the 15th: “The Norwegian Medicines Agency reported on January 14 that the initial assessment of 13 of the deceased persons determined that the deaths may be related to the Generally mild side effects of this vaccine. These 13 People are frail elderly. “
The spokesman said WHO “will remain in contact with Norwegian health authorities and will closely monitor investigations into the causes and circumstances of the 23 deaths.”
Norway: notified to reduce vaccine supply
The Norwegian Institute of Public Health said in an announcement on the 15th that Pfizer notified that it will reduce the supply of vaccines for a period of time starting next week. The reason is that Pfizer will adjust production procedures to increase production, including vaccines in many European countries, including Norway. Supply will be temporarily affected by this.
More than 30,000 people in Norway have received the first dose of the Pfizer vaccine. The first batch of vaccines includes medical personnel and elderly people in nursing homes.
The EU has announced the purchase of 300 million doses of vaccine
The president of the European Commission, Von Delane, said on the 8th that the European Union has reached an agreement with Pfizer Pharmaceuticals Co., Ltd. of the United States and the new biotechnology company of Germany to buy 300 million doses of the new corona vaccine developed jointly by the two companies.
Von der Lein told a press conference that day that the European Union had previously ordered 300 million doses of the vaccine, and now an additional 300 million doses have been purchased, doubling the supply of the vaccine to the EU. The new part will be supplied from the second quarter of 2021 and will be completed in the fourth quarter.
At present, the European Union has approved the conditional inclusion of two new corona vaccines, one is a vaccine jointly developed by Pfizer Pharmaceuticals Co., Ltd. of the United States and a German biotechnology company, and the other is a vaccine developed by Modena from the United States. The total supply of these two vaccines to the EU is 760 million doses, which can meet the epidemic prevention needs of 380 million people (about 80% of the total EU population).
Von der Lein said the EU will evaluate more vaccine candidates in the coming weeks and months. He said the European Commission has signed six new procurement contracts for crown vaccines on behalf of the 27 EU countries. The total supply in the future will reach 2.3 billion doses, which can meet the needs of the EU and partner countries and regions.
Center for Disease Control and Prevention:
21 allergic reactions have been reported after vaccination with Pfizer
A report issued by the U.S. Centers for Disease Control and Prevention on Day 6 showed that, as of December 23, 2020, a total of 1,893,360 people in the United States had received the first dose of the Pfizer vaccine and a total of 4,393 adverse events were reported (the rate of adverse reactions was approximately 0.2%), including 21 allergic reactions.
In December 2020, the US Food and Drug Administration approved the emergency use authorization application for the new corona vaccine jointly developed by Pfizer Pharmaceuticals Co., Ltd. and German Biotech. This is the first new coronavirus vaccine approved for emergency use in the United States. It is allowed to be used by people 16 years of age or older. A total of two doses 21 days apart.
According to the website of the US Centers for Disease Control and the US Drug Administration, adverse reactions from this vaccine in previous clinical trials include local redness and swelling, headaches, fatigue, etc. After the United States and the United Kingdom began receiving this vaccine, several reported allergic reactions have attracted a lot of attention.
Earlier, the British drug regulatory agency had stated that it had issued preventive advice to the relevant health agencies. Anyone who has had a “significant” allergic reaction to a drug, food, or vaccine should not receive the vaccine.
[ad_2]
